Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TOBRAMYCIN Cause Mycobacterium avium complex infection? 8 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Mycobacterium avium complex infection have been filed in association with TOBRAMYCIN (TOBRAMYCIN). This represents 0.1% of all adverse event reports for TOBRAMYCIN.

8
Reports of Mycobacterium avium complex infection with TOBRAMYCIN
0.1%
of all TOBRAMYCIN reports
1
Deaths
4
Hospitalizations

How Dangerous Is Mycobacterium avium complex infection From TOBRAMYCIN?

Of the 8 reports, 1 (12.5%) resulted in death, 4 (50.0%) required hospitalization.

Is Mycobacterium avium complex infection Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TOBRAMYCIN. However, 8 reports have been filed with the FAERS database.

What Other Side Effects Does TOBRAMYCIN Cause?

Off label use (1,467) Death (888) Cough (738) Dyspnoea (706) Pneumonia (700) Hospitalisation (688) Condition aggravated (669) Cystic fibrosis (646) Infective pulmonary exacerbation of cystic fibrosis (504) Drug ineffective (453)

What Other Drugs Cause Mycobacterium avium complex infection?

PREDNISONE (300) AMIKACIN (274) ETHAMBUTOL (228) TACROLIMUS (164) RIFAMPIN (152) AZITHROMYCIN (143) METHOTREXATE (127) MYCOPHENOLATE MOFETIL (124) ALBUTEROL (121) TIOTROPIUM (117)

Which TOBRAMYCIN Alternatives Have Lower Mycobacterium avium complex infection Risk?

TOBRAMYCIN vs TOBRAMYCIN\TOBRAMYCIN TOBRAMYCIN vs TOCILIZUMAB TOBRAMYCIN vs TOCILIZUMAB-AAZG TOBRAMYCIN vs TOCOPHEROL TOBRAMYCIN vs TOFACITINIB

Related Pages

TOBRAMYCIN Full Profile All Mycobacterium avium complex infection Reports All Drugs Causing Mycobacterium avium complex infection TOBRAMYCIN Demographics